On March 16, 2019, Dementia Friendly Tempe held its fourth annual community summit to help the public understand more about dementia and related disease. The two speakers who represented the dementia research community were Dr. Eric M. Reiman from the Banner Alzheimer’s Institute and Professor Diego Mastroeni from the ASU-Banner Neurodegenerative Disease Research Center.
For attendees who may be interested in more information, we have provided links to their work and research.
Banner Alzheimer’s Institute
Through its research and care, Banner Alzheimer’s Institute is dedicated to the goal of ending Alzheimer’s disease without losing another generation. To support BAI programs and services go to give.bannerhealth.com/Alzheimers.
ASU-BANNER Neurodegenerative Disease Research Center
The Neurodegenerative Disease Research Center aggressively pursues new battleground tactics in the war against Alzheimer’s and other neurodegenerative diseases.
Executive Director of the Banner Alzheimer’s Institute, Chief Executive Officer of Banner Research, Professor of Psychiatry at the University of Arizona, University Professor of Neuroscience at Arizona State University, Clinical Director of Neurogenomics at the Translational Genomics Research Institute, and Director of the Arizona Alzheimer’s Consortium.
Dr. Reiman’s research interests include brain imaging, genomics, the unusually early detection and tracking of Alzheimer’s disease, and the accelerated evaluation of Alzheimer’s prevention therapies. He is also interested in new models of research collaboration and dementia care. He and his Banner Alzheimer’s Institute colleagues lead the Alzheimer’s Prevention Initiative (API), including prevention trials in cognitively unimpaired persons who, based on their genetic background and age, are at high risk for Alzheimer’s disease, biomarker development and data and sample sharing agreements, unusually large registries to support enrollment in prevention trials, and other efforts to help accelerate the evaluation, approval and availability of prevention therapies.
Dr. Reiman is an author of more than 400 publications, a principal investigator of several NIH grants, and a recipient of the Potamkin Prize.
BAI in the media:
Professor Diego Mastroeni:
Assistant Research Professor, ASU-Banner Neurodegenerative Disease Research Center
Diego Mastroeni's current research is examining genetic changes within the brain regions affected early in Alzheimer's disease and Parkinson's disease. Results could shed new light on the genetic basis of glial dysfunction in dementia. It could also lead to more targeted therapies for Alzheimer's and Parkinson's diseases.
Mastroeni in the media: